Global Apomorphine Hydrochloride Industry Growth and Trends Forecast to 2031

Summary

Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.

According to APO Research, The global Apomorphine Hydrochloride market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Apomorphine Hydrochloride is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Apomorphine Hydrochloride is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Apomorphine Hydrochloride is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Apomorphine Hydrochloride include Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma, Evolan Pharma AB (PharmSwed), Tianjin Tianwei Pharmaceutical and Sunovion, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Apomorphine Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Apomorphine Hydrochloride.

The Apomorphine Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Apomorphine Hydrochloride market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Apomorphine Hydrochloride Segment by Company

Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
Ever Pharma
Evolan Pharma AB (PharmSwed)
Tianjin Tianwei Pharmaceutical
Sunovion

Apomorphine Hydrochloride Segment by Type

Injection
Tablets
Thinfilm
Nasal Powder (Pipeline)

Apomorphine Hydrochloride Segment by Application

Parkinson Disease
Erectile Dysfunction

Apomorphine Hydrochloride Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Apomorphine Hydrochloride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Apomorphine Hydrochloride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Apomorphine Hydrochloride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Apomorphine Hydrochloride manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Apomorphine Hydrochloride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview

1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Apomorphine Hydrochloride Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Apomorphine Hydrochloride Sales Estimates and Forecasts (2020-2031)
1.3 Apomorphine Hydrochloride Market by Type
1.3.1 Injection
1.3.2 Tablets
1.3.3 Thinfilm
1.3.4 Nasal Powder (Pipeline)
1.4 Global Apomorphine Hydrochloride Market Size by Type
1.4.1 Global Apomorphine Hydrochloride Market Size Overview by Type (2020-2031)
1.4.2 Global Apomorphine Hydrochloride Historic Market Size Review by Type (2020-2025)
1.4.3 Global Apomorphine Hydrochloride Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Apomorphine Hydrochloride Sales Breakdown by Type (2020-2025)
1.5.2 Europe Apomorphine Hydrochloride Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Apomorphine Hydrochloride Sales Breakdown by Type (2020-2025)
1.5.4 South America Apomorphine Hydrochloride Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Apomorphine Hydrochloride Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics

2.1 Apomorphine Hydrochloride Industry Trends
2.2 Apomorphine Hydrochloride Industry Drivers
2.3 Apomorphine Hydrochloride Industry Opportunities and Challenges
2.4 Apomorphine Hydrochloride Industry Restraints
3 Market Competitive Landscape by Company

3.1 Global Top Players by Apomorphine Hydrochloride Revenue (2020-2025)
3.2 Global Top Players by Apomorphine Hydrochloride Sales (2020-2025)
3.3 Global Top Players by Apomorphine Hydrochloride Price (2020-2025)
3.4 Global Apomorphine Hydrochloride Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Apomorphine Hydrochloride Major Company Production Sites & Headquarters
3.6 Global Apomorphine Hydrochloride Company, Product Type & Application
3.7 Global Apomorphine Hydrochloride Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Apomorphine Hydrochloride Market CR5 and HHI
3.8.2 Global Top 5 and 10 Apomorphine Hydrochloride Players Market Share by Revenue in 2024
3.8.3 2023 Apomorphine Hydrochloride Tier 1, Tier 2, and Tier 3
4 Apomorphine Hydrochloride Regional Status and Outlook

4.1 Global Apomorphine Hydrochloride Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Apomorphine Hydrochloride Historic Market Size by Region
4.2.1 Global Apomorphine Hydrochloride Sales in Volume by Region (2020-2025)
4.2.2 Global Apomorphine Hydrochloride Sales in Value by Region (2020-2025)
4.2.3 Global Apomorphine Hydrochloride Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Apomorphine Hydrochloride Forecasted Market Size by Region
4.3.1 Global Apomorphine Hydrochloride Sales in Volume by Region (2026-2031)
4.3.2 Global Apomorphine Hydrochloride Sales in Value by Region (2026-2031)
4.3.3 Global Apomorphine Hydrochloride Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Apomorphine Hydrochloride by Application

5.1 Apomorphine Hydrochloride Market by Application
5.1.1 Parkinson Disease
5.1.2 Erectile Dysfunction
5.2 Global Apomorphine Hydrochloride Market Size by Application
5.2.1 Global Apomorphine Hydrochloride Market Size Overview by Application (2020-2031)
5.2.2 Global Apomorphine Hydrochloride Historic Market Size Review by Application (2020-2025)
5.2.3 Global Apomorphine Hydrochloride Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Apomorphine Hydrochloride Sales Breakdown by Application (2020-2025)
5.3.2 Europe Apomorphine Hydrochloride Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Apomorphine Hydrochloride Sales Breakdown by Application (2020-2025)
5.3.4 South America Apomorphine Hydrochloride Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Apomorphine Hydrochloride Sales Breakdown by Application (2020-2025)
6 Company Profiles

6.1 Supernus Pharmaceuticals
6.1.1 Supernus Pharmaceuticals Comapny Information
6.1.2 Supernus Pharmaceuticals Business Overview
6.1.3 Supernus Pharmaceuticals Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Supernus Pharmaceuticals Apomorphine Hydrochloride Product Portfolio
6.1.5 Supernus Pharmaceuticals Recent Developments
6.2 Britannia Pharmaceuticals STADA
6.2.1 Britannia Pharmaceuticals STADA Comapny Information
6.2.2 Britannia Pharmaceuticals STADA Business Overview
6.2.3 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Product Portfolio
6.2.5 Britannia Pharmaceuticals STADA Recent Developments
6.3 Ever Pharma
6.3.1 Ever Pharma Comapny Information
6.3.2 Ever Pharma Business Overview
6.3.3 Ever Pharma Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Ever Pharma Apomorphine Hydrochloride Product Portfolio
6.3.5 Ever Pharma Recent Developments
6.4 Evolan Pharma AB (PharmSwed)
6.4.1 Evolan Pharma AB (PharmSwed) Comapny Information
6.4.2 Evolan Pharma AB (PharmSwed) Business Overview
6.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Product Portfolio
6.4.5 Evolan Pharma AB (PharmSwed) Recent Developments
6.5 Tianjin Tianwei Pharmaceutical
6.5.1 Tianjin Tianwei Pharmaceutical Comapny Information
6.5.2 Tianjin Tianwei Pharmaceutical Business Overview
6.5.3 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Product Portfolio
6.5.5 Tianjin Tianwei Pharmaceutical Recent Developments
6.6 Sunovion
6.6.1 Sunovion Comapny Information
6.6.2 Sunovion Business Overview
6.6.3 Sunovion Apomorphine Hydrochloride Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sunovion Apomorphine Hydrochloride Product Portfolio
6.6.5 Sunovion Recent Developments
7 North America by Country

7.1 North America Apomorphine Hydrochloride Sales by Country
7.1.1 North America Apomorphine Hydrochloride Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Apomorphine Hydrochloride Sales by Country (2020-2025)
7.1.3 North America Apomorphine Hydrochloride Sales Forecast by Country (2026-2031)
7.2 North America Apomorphine Hydrochloride Market Size by Country
7.2.1 North America Apomorphine Hydrochloride Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Apomorphine Hydrochloride Market Size by Country (2020-2025)
7.2.3 North America Apomorphine Hydrochloride Market Size Forecast by Country (2026-2031)
8 Europe by Country

8.1 Europe Apomorphine Hydrochloride Sales by Country
8.1.1 Europe Apomorphine Hydrochloride Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Apomorphine Hydrochloride Sales by Country (2020-2025)
8.1.3 Europe Apomorphine Hydrochloride Sales Forecast by Country (2026-2031)
8.2 Europe Apomorphine Hydrochloride Market Size by Country
8.2.1 Europe Apomorphine Hydrochloride Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Apomorphine Hydrochloride Market Size by Country (2020-2025)
8.2.3 Europe Apomorphine Hydrochloride Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country

9.1 Asia-Pacific Apomorphine Hydrochloride Sales by Country
9.1.1 Asia-Pacific Apomorphine Hydrochloride Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Apomorphine Hydrochloride Sales by Country (2020-2025)
9.1.3 Asia-Pacific Apomorphine Hydrochloride Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Apomorphine Hydrochloride Market Size by Country
9.2.1 Asia-Pacific Apomorphine Hydrochloride Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Apomorphine Hydrochloride Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Apomorphine Hydrochloride Market Size Forecast by Country (2026-2031)
10 South America by Country

10.1 South America Apomorphine Hydrochloride Sales by Country
10.1.1 South America Apomorphine Hydrochloride Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Apomorphine Hydrochloride Sales by Country (2020-2025)
10.1.3 South America Apomorphine Hydrochloride Sales Forecast by Country (2026-2031)
10.2 South America Apomorphine Hydrochloride Market Size by Country
10.2.1 South America Apomorphine Hydrochloride Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Apomorphine Hydrochloride Market Size by Country (2020-2025)
10.2.3 South America Apomorphine Hydrochloride Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country

11.1 Middle East and Africa Apomorphine Hydrochloride Sales by Country
11.1.1 Middle East and Africa Apomorphine Hydrochloride Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Apomorphine Hydrochloride Sales by Country (2020-2025)
11.1.3 Middle East and Africa Apomorphine Hydrochloride Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Apomorphine Hydrochloride Market Size by Country
11.2.1 Middle East and Africa Apomorphine Hydrochloride Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Apomorphine Hydrochloride Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Apomorphine Hydrochloride Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis

12.1 Apomorphine Hydrochloride Value Chain Analysis
12.1.1 Apomorphine Hydrochloride Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Apomorphine Hydrochloride Production Mode & Process
12.2 Apomorphine Hydrochloride Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Apomorphine Hydrochloride Distributors
12.2.3 Apomorphine Hydrochloride Customers
13 Concluding Insights
14 Appendix

14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings